11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – borsyra

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Borsyra – lokalt

Borsyra – lokalt

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Moore JA. An assessment of boric acid and borax using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents Expert Scientific Committee. Reprod Toxicol. 1997;11(1):123-60.

  2. Apotek Produktion & Laboratorier (APL). Borsyra APL 600 mg Vagitorium. Produktresumé. Apotek Produktion & Laboratorier (APL) [www]. [updated 2022-03-11, cited 2023-06-09].

  3. Mittelstaedt R, Kretz A, Levine M, Handa VL, Ghanem KG, Sobel JD et al. Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review. Sex Transm Dis. 2021;48(12):e241-e247.

  4. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.

  5. Acs N, Bánhidy F, Puhó E, Czeizel AE. Teratogenic effects of vaginal boric acid treatment during pregnancy. Int J Gynaecol Obstet. 2006;93(1):55-6.

  6. Igra AM, Harari F, Lu Y, Casimiro E, Vahter M. Boron exposure through drinking water during pregnancy and birth size. Environ Int. 2016;95(0):54-60.

  7. Duydu Y, Başaran N, Üstündağ A, Aydın S, Yalçın CÖ, Anlar HG et al. Birth weights of newborns and pregnancy outcomes of environmentally boron-exposed females in Turkey. Arch Toxicol. 2018;92(8):2475-2485.

  8. Reprotox. Boric acid. Micromedex [www]. [cited 2023-06-02].

  9. EMA. Boric acid and borate used as excipients. EMA [www]. [updated 2021-11-11, cited 2023-06-02].

  1. Moore JA. An assessment of boric acid and borax using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents Expert Scientific Committee. Reprod Toxicol. 1997;11(1):123-60.
  2. Apotek Produktion & Laboratorier (APL). Borsyra APL 600 mg Vagitorium. Produktresumé. Apotek Produktion & Laboratorier (APL) [www]. [updated 2022-03-11, cited 2023-06-09].
  3. Mittelstaedt R, Kretz A, Levine M, Handa VL, Ghanem KG, Sobel JD et al. Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review. Sex Transm Dis. 2021;48(12):e241-e247.
  4. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.
  5. Acs N, Bánhidy F, Puhó E, Czeizel AE. Teratogenic effects of vaginal boric acid treatment during pregnancy. Int J Gynaecol Obstet. 2006;93(1):55-6.
  6. Igra AM, Harari F, Lu Y, Casimiro E, Vahter M. Boron exposure through drinking water during pregnancy and birth size. Environ Int. 2016;95(0):54-60.
  7. Duydu Y, Başaran N, Üstündağ A, Aydın S, Yalçın CÖ, Anlar HG et al. Birth weights of newborns and pregnancy outcomes of environmentally boron-exposed females in Turkey. Arch Toxicol. 2018;92(8):2475-2485.
  8. Reprotox. Boric acid. Micromedex [www]. [cited 2023-06-02].
  9. EMA. Boric acid and borate used as excipients. EMA [www]. [updated 2021-11-11, cited 2023-06-02].